WGS250502C117000
- 0.05
- -9.55-99.48%
GeneDx Holdings Newsroom
GeneDx Holdings (WGS) Gets a Hold From Wells Fargo
GeneDx Holdings: Strong Growth Potential and Strategic Acquisitions Drive Buy Rating
Small U.S. Stocks Decrease; GeneDx Holdings Falls Furthest
GeneDx Holdings Corp. (WGS) Q1 2025 Earnings Call Transcript Summary
GeneDx Raises 2025 Revenue Guidance to $360M-$375M and Expands NICU Offerings
Crude Oil Falls Over 3%; Regulus Therapeutics Shares Spike Higher
GeneDx Holdings Down Nearly 39%, On Pace For Record Percent Decrease -- Data Talk
S&P 500 Falls 2%; Caterpillar Reports Downbeat Q1 Results
Analysts Offer Insights on Healthcare Companies: Ocular Therapeutix (OCUL), Xencor (XNCR) and GeneDx Holdings (WGS)
Sector Update: Health Care Stocks Decline Pre-Bell Wednesday
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Express News | GeneDx Shares Down 29.3% Premarket After Q1 Results
10-Q: Quarterly report
8-K: GeneDx Reports First Quarter 2025 Financial Results and Business Highlights
Express News | GeneDx Holdings Corp Outlook Full Year Revenues Between $360 to $375 Mln
Express News | GeneDx Q1 Adjusted Net Income USD 7.7 Million
Express News | GeneDx Q1 Net Income USD -6.5 Million
GeneDx Holdings 1Q Loss/Shr 23c >WGS
GeneDx Holdings 1Q Rev $87.1M >WGS
Press Release: GeneDx Reports First Quarter 2025 Financial Results and Business Highlights